Danielle Barron
Danielle Barron
Latest posts from :
Health technology assessment is building up steam in the US – and pharma...
A patient-first strategy is important but without the culture to back it up,...
Merck EVP Dr. Julie Gerberding has not followed a classic professional path,...
Regulatory changes are paving the way for speedier access to biosimilars in the...
One company is literally 'talking the talk' on patient-centricity...
Pharma’s commercial model is rapidly evolving. But where will it be in twenty...
A unique collaboration has seen patients, caregivers, clinicians and industry...
In-home visits are making clinical trials more convenient for patients - and...
AstraZeneca is going back to basics by publishing a definition of patient...
Companies must demonstrate meaningful clinical outcomes to guarantee access to...